2 Stocks Set to Capitalize on the Surging Weight Loss Drug Trend

With over a billion obese individuals globally and many obesity-related cancers and diabetes cases in the US, weight loss drugs have become a thriving commodity. This trend, accelerated by the power of social media, has spurred pharmaceutical companies to develop weight-reduction drugs, and some of them are doing very well. According to Morgan Stanley, the weight loss drug market is expected to reach $77 billion in 2030, and these two stocks will likely play a key role in the industry.

Should Wegovy obtain insurance coverage, its current cost of $1,349 per month would likely get reduced significantly, potentially further boosting Novo Nordisk’s profits and stock price. The company’s stock is already up over 38% year-to-date, thanks to the success of its diabetes drug Ozempic. In a recent report, analysts at BMO Capital Markets noted “unprecedented potential” for Eli Lilliy’s A-list group of drugs, including Mounjaro, oral orforglipron, and the next-gen retatutide. The investment firm holds an outperform rating on Lilly shares, with a target price of $633. Its shares are currently priced at $607.2 apiece, up 66% this year.

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

3 Stocks That Can Be Potential Short Squeeze PlaysStocks Analysis by The Tokenist (Timothy Fries) covering: Microsoft Corporation, Qualcomm Incorporated, GameStop Corp, Tesla Inc. Read The Tokenist (Timothy Fries)'s latest article on Investing.com
Source: Investingcom - 🏆 450. / 53 Read more »

Japanese stocks climb for second day as Hong Kong stocks dropSupported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with unparalleled accuracy.
Source: MarketWatch - 🏆 3. / 97 Read more »

European stocks set for muted open as traders track earnings, inflation dataEuropean markets are set for a cautious open as traders monitor corporate earnings and developments in the Middle East, along with key inflation data.
Source: CNBC - 🏆 12. / 72 Read more »

European stocks set for muted open as traders track earnings, inflation dataEuropean markets are set for a cautious open as traders monitor corporate earnings and developments in the Middle East, along with key inflation data.
Source: NBCLA - 🏆 319. / 59 Read more »

CNBC Daily Open: Bonds are driving stocks even amid big bank earningsMarkets wavered Tuesday as investors digested September’s U.S. retail sales report and third-quarter earnings from banks.
Source: nbcchicago - 🏆 545. / 51 Read more »

CNBC Daily Open: Bonds are driving stocks even amid big bank earningsMarkets wavered Tuesday as investors digested September’s U.S. retail sales report and third-quarter earnings from banks.
Source: NBCLA - 🏆 319. / 59 Read more »